Le Lézard
Classified in: Health
Subject: CCA

Intec Pharma to Present at H.C. Wainwright 22nd Annual Global Investment Conference


JERUSALEM, Sept. 8, 2020 /PRNewswire/ -- Intec Pharma Ltd. (NASDAQ: NTEC) ("Intec" or "the Company") today announces that the Company management will present at the virtual H.C. Wainwright 22nd Annual Global Investment Conference.

H.C. Wainwright 22nd Annual Global Investment Conference
Date: September 14 ? 16, 2020
Company Presentation: Tuesday, September 15, 2020 at 4:30 pm (ET)
Presenter: Jeffrey A. Meckler, Vice Chairman and Chief Executive Officer of Intec Pharma
Format: Corporate Presentation and One-on-One Investor Meetings

Mr. Meckler's presentation will be webcast live and will be accessible through the Events section of Intec Pharma's website at www.intecpharma.com, where it will also be archived for a period of time. 

About Intec Pharma Ltd.

Intec Pharma is a clinical-stage biopharmaceutical company focused on developing drugs based on its proprietary Accordion Pill platform technology. The Company's Accordion Pill is an oral drug delivery system that is designed to improve the efficacy and safety of existing drugs and drugs in development by utilizing an efficient gastric retention and specific release mechanism. The Company's product pipeline includes two product candidates in clinical trial stages: Accordion Pill Carbidopa/Levodopa, or AP-CD/LD, which is in late-stage Phase 3 development for the treatment of Parkinson's disease symptoms in advanced Parkinson's disease patients, and AP-cannabinoids, an Accordion Pill to deliver either or both of the primary cannabinoids contained in Cannabis sativa, cannabidiol (CBD) and tetrahydrocannabinol (THC) for various pain indications. In addition, the Company has a research collaboration with Merck & Co.

For more information, visit www.intecpharma.com. Intec Pharma routinely posts information that may be important to investors in the Investor Relations section of its website.

Intec Pharma Investor Contact:

Will O'Connor
Stern IR
+1 212-362-1200
[email protected]


SOURCE Intec Pharma Ltd.


These press releases may also interest you

at 18:42
Specsavers Awarded Best Workplacestm in Canada
Specsavers was recognized in Canada's Best Workplacestm List for 2024 by Great Place To Work®, the global authority on workplace culture. The Company is proud to rank as the highest optical retailer in the medium-sized company category after entering...

at 18:30
BayCare's St. Joseph's Hospital Opens Season's Café with Amazon's Just Walk Out Technology
St. Joseph's Hospital today announced that it becomes the first health care facility to use checkout-free technology in a hospital cafeteria, demonstrating BayCare and St. Joseph's Hospital's commitment to innovation, patient care and team member...

at 17:46
Wounded Warrior Project, White House Celebrate and Honor Warriors at Annual Soldier Ride
Veterans with Wounded Warrior Project® (WWP) kicked off the organization's annual Soldier Ride® in the nation's capital with First Lady Jill Biden at the White House today. As part of her Joining Forces initiative to support military and veteran...

at 17:45
Tiger Aesthetics Medical, LLC Acquires Assets of Sientra, Inc.
Tiger Aesthetics Medical, LLC today announced its acquisition of substantially all of the assets associated with the Sientra Inc. breast implant business. This strategic acquisition will complement Tiger Aesthetics' upcoming adipose cell and tissue...

at 17:31
Stargardt Disease Market to Grow Rapidly at a CAGR of 32% by 2034 | DelveInsight
DelveInsight's Stargardt Disease Market Insights report includes a comprehensive understanding...

at 17:30
Dr. Simon Ourian's Revolutionary Acne Scar Treatments Coolaser® and Neustem® at Epione Beverly Hills
Renowned cosmetic dermatology specialist Dr. Simon Ourian at Epione Beverly Hills introduces a groundbreaking solution to acne...

More news about Health...


News published on and distributed by: